Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

9Total

N/A(6)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07526324Not ApplicableNot Yet Recruiting

Difelikefalin for Itching in Hemodialysis Patients With Chronic Kidney Disease

Role: lead

NCT07262723Phase 2Not Yet Recruiting

Levosimendan in Acute Decompensated Heart Failure

Role: lead

NCT06847139Not ApplicableRecruiting

Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis

Role: lead

NCT06918405Phase 3Active Not Recruiting

Efficacy and Safety of Tirzepatide for Weight Management

Role: lead

NCT06502288Not ApplicableNot Yet Recruiting

Evaluation of Antibiotic Administration Following Tooth Extraction

Role: lead

NCT06403124Not ApplicableCompleted

Outcome of Operative Management of Posterior Wall of Acetabulum Fracture

Role: lead

NCT05021718Not ApplicableCompleted

Strengthening Exercise and Activities of Daily Living Instructions for Patients With Lumbar Disc Herniation

Role: lead

NCT04977557Not ApplicableCompleted

Thiamine in Patients With Clinically Suspected Dry Beriberi

Role: lead

NCT04205201Phase 2Completed

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

Role: lead

All 9 trials loaded